Ongoing supervision Regular check-ins to monitor your progress, manage any side effects, and adjust your dose
It is approved by the MHRA, meaning it has met the UK standards for safety, quality and effectiveness
In brief: Chemical nature: a synthetic organic compound, a methylquinolinium salt
Interestingly, the data from the VENTURE Oral trial saw a reduced dose successfully maintain weight loss
Accordingly, currently ongoing trials in HF (HFpEF) with the GLP-1 RA semaglutide (2.4 mg for once-weekly subcutaneous injection, i.e., the dose approved for weight management) enrols people with obesity with (STEP-HFpEF DM trial
While this may not seem like a huge difference in absolute terms, it resulted in 24% of the prediabetic patients enrolled in this study no longer being classified as prediabetic by the end of the study period